The International Diabetes Federation (IDF) is drawing up new guidelines for the treatment ... with the latest updates as far as professional education goes. So the goal is that the colleagues ...
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its "calming agent" action in turning off the body's inflammatory response and preventing chronic ...